Proterris
0 followers
‌
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Industries
Headquarters
Employees
Links
Org chart
Jeffrey Wager
Collapse
Kourosh Saeb-Parsy
Acting Chief Medical Officer
Jim Potenziano
Chief Operating Officer
